Matt Maisak
About Matt Maisak
Professional Background at Roivant Platforms
Matt Maisak, PhD, has been serving as Chief Operating Officer at Roivant Platforms since 2018. He has played a significant role in the development and growth of the company. As a key member of the Axovant business development team, he focused on advancing strategic initiatives to enhance Roivant's business portfolio. His leadership in the in-licensing efforts for the GM1 and GM2 gangliosidoses gene therapy programs from the University of Massachusetts highlights his contribution to cutting-edge therapeutic advancements.
Career at Roche Diagnostics
Before joining Roivant, Matt Maisak held several strategic roles at Roche Diagnostics. His work spanned across regulatory and manufacturing strategy, emphasizing the importance of streamlined operations in global healthcare. His experience at Roche provided him with a robust foundation in managing complex business environments and implementing regulatory strategies critical to the successful launch of diagnostic products.
Education and Research
Matt Maisak earned his PhD from the Max Planck Institute, where he investigated the role of single neuronal subtypes in the computation of direction selective motion vision. His academic research has been published in prestigious journals such as Nature and Current Biology. Additionally, Matt studied medicine at Yale University School of Medicine. His work has garnered attention from popular science media, being featured in National Geographic and Bayerischer Rundfunk.
Published Work and Media Features
Matt Maisak's research contributions have been widely recognized in the scientific community. His work has been published in high-impact journals such as Nature and Current Biology, reflecting the significance of his findings. Beyond academic circles, his work has also been featured in popular science media including National Geographic (Geo) and Bayerischer Rundfunk, reaching a broader audience and emphasizing the real-world implications of his scientific research.